Publikationer

1. Binzer M, Forsgren L, Holmgren G, Drugge U, Fredrikson S. Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994;57:497-499.

2. Lindsten H, Binzer M, Boman J, Juto P. Guillain-Barré vid samtidig CMV – infektiös och neurologisk förbättring med ganciklovir. Läkartidningen 1994;12:1227-1228.

3. Liedholm LJ, Gard A, Binzer M, Fredrikson S. Multipel skleros – det finns imitatörer! Nord Med 1995;110:184-7.

4. Andersen PM, Nilsson P, Ala-Hurula V, Keränen ML, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, Marklund SL. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics 1995;10:61-66.

5. Ingemansson K, Ingemansson E, Bergvall U, Binzer M. Akut disseminerad encefalomyelit – ADEM ovanlig men svår sjukdom. Läkartidningen 1995;92:4589-4593.

6. Binzer M, Kullgren G. Conversion symptoms: What can we learn from previous studies? Nord J Psychiatry 1996;50:143-152.

7. Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keränen ML, Bergmark L, Saarinen A, Haltia T, Tarvainen I, Kinnunen E, Udd B, Marklund SL. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation – A clinical and genealogical study of 36 patients. Brain 1996;119:1153-1172.

8. Binzer M, Gredal O, Brøndum-Nielsen K, Andersen PM. Amyotrofisk lateral sklerose og superoxid dismutase – en oversigt. Ugeskrift for læger 1997;159:1593-96.

9. Häggström B, Andersen PM, Hjalmarsson K, Binzer M, Forsgren L. Autoimmunity and ALS: Studies on Antibodies to Acetylcholinesterase in sera. Acta Neurol Scand 1997;95:111-114.

10. Binzer M, Andersen PM, Kullgren G. Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study. J Neurol Neurosurg Psychiatry 1997;Vol 63, No 1:83-88.

11. Binzer M, Eisemann M, Kullgren G. Illness behaviour in the acute phase of motor disability in neurological disease and in conversion disorder: a comparative study. J Psychosom Res 1998;4:657-666.

12. Binzer M. Hopelessness and Locus of Control in Patients with Motor Conversion Disorder. Nord J Psychiatry 1999;53:37-40.

13. Binzer M, Eisemann M. Childhood experiences and personality traits in patients with motor conversion disorder. Acta Psychiat Scand 1998;98:288-295.

14. Sundbom E, Binzer M, Kullgren G. Psychological Defensive Strategies according to Defense Test Mechanism among patients with severe Conversion Disorder. Psychother Res 1999;9:184-198.

15. Binzer M, Kullgren M. Motor conversion disorder – A 2-5 year follow-up study. Psychosomatics 1998;39:519-527.

16. Binzer M, Brattström L, Ottosen P, Videbæk H, Stenager E. Kliniske, radiologiske, histopatologiske samt genetiske fund i en dansk ”CADASIL” familie. Ugeskrift for Læger 2000;162:1739-1742.

17. Andersen PM, Binzer M. Treatment of amyotrophic lateral sclerosis. Ugeskr Laeger. 1999 Oct 11;161(41):5697-8.

18. Binzer M, Kullgren G. Psychogenic paralysis. A prospective study. Ugeskr Laeger. 2000 Oct 16;162(42):5632-6.

19. Madsen B, Binzer M. Restless legs – diagnose og behandling. Månedsskr Prakt Lægegern 2001;79:491-497.

20. Rasmussen MJK, Binzer M. Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Migraine. Current Medical Research 2001;17:26-29.

21. Stenager E, Binzer M. Woman with Facial Spasm Induced Exclusively by Sound. Movement Disorders 2002;17:1-2.

22. He B, Giedraitis V, Ligers A, Binzer M, Andersen PM, Forsgren L, Sandkuijl LA, Hillert J. Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11. Eur J Hum Genet 2002;10(4):271-5.

23. Binzer M, Almay B, Eisemann M. Chronic Pain Disorder Associated with Psychologic Factors versus Chronic Pain Disorder Associated with a General Medical Condition: a Comparativ Study. Nord J Psychiatry, 2003;57:61-66.

24. Binzer M, Stone J, Sharpe M. Recent onset pseudoseizures – clues to aetiology. Seizure 2004;13:146-155.

25. Juhl S, Shorsh K, Videbæk H, Binzer M. Samtidig arteriel og venøs cerebral thrombose hos bodybuilder med svær hyperhomocysteinæmi og misbrug af anaboliske steroider. Ugeskrift for læger 2004; 166:3508-3509.

26. Stone J, Sharpe M, Binzer M. Motor Conversion Symptoms and Pseudoseizures: A Comparison of Clinical Characteristics. Psychosomatics 2004; 45:492-499.

27. Stone J, Binzer M, Sharpe M. Illness beliefs and locus of control: A comparison of patients with pseudoseizures and epilepsy. J Psychosom Res 2004; 57:541-547.

28. Shorsh K, Binzer M. Kliniske procedurer – lumbalpunktur. Ugeskrift for læger 2005; 167:4285-6.

29. Binzer M. Konversionssyndromer. Kap.1 i Hjernen vil bedrages. Udg. Hjerneforum. 2006. Red. Ellemann K. Bøgeskov J.

30. Gotfredssen K, Binzer M, Larsen JT. Kap 7 i Neurologi og neurorehabilitering. Udg. Munksgård. 2006; 7:93-99. Red. Wæhrens E, Winkel, A, Gyring J.

31. Binzer M, Shorsh K. Botulinum toxin A in the treatment of chronic whiplash associated disorder – A double blind placebo controlled crossover study. Manuscript.

32. Binzer M, Kullgren G. Belle indifference and secondary gain in conversion disorder and neurological disease. Manuscript.

33. Binzer M, Stenager EN, Stenager E. Clinical characteristics of 222 patients with chronic whiplash syndrome awaiting litigation. Manuscript.

34. Multiple sclerosis in a family on the Faroe Islands. Binzer S, Imrell K, Binzer M, Vang S, Rogvi-Hansen B, Hillert J, Stenager E. Acta Neurol Scand. 2010 Jan;121(1):16-9.

35. Every fifth case of multiple sclerosis is familial. Binzer S, Binzer M, Kyvik KO, Imrell K, Hillert J, Stenager E. Ugeskr Laeger. 2014 Jan 13;176(3A):V04130245. Review. Danish.

36. High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis. Binzer S, Imrell K, Binzer M, Kyvik KO, Hillert J, Stenager E. Mult Scler. 2015 Jul;21(8):996-1002.

37. Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene. Binzer S, Stenager E, Binzer M, Kyvik KO, Hillert J, Imrell K. Mult Scler. 2016 May;22(6):733-40.

38. Cerebrospinal fluid biomarkers for Parkinson’s disease – a systematic review. Andersen AD, Binzer M, Stenager E, Gramsbergen JB. Acta Neurol Scand. 2017 Jan;135(1):34-56. doi: 10.1111/ane.12590. Review.

39. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson’s disease: Effect of L-DOPA treatment and changes in levodopa-induced dyskinesia. Andersen AD, Blaabjerg M, Binzer M, Kamal A, Thagesen H, Kjaer TW, Stenager E, Gramsbergen JB. J Neurochem. 2017 Feb 28. doi: 10.1111/jnc.13997.